The Occurrence of Single Nucleotide Polymorphism Among Women Who Experienced Obstetric Anal Sphincter Injury
1 other identifier
interventional
93
1 country
1
Brief Summary
Single-nucleotide polymorphisms (SNP's) in connective tissue components are associated with increased risk of pelvic organ prolapse (POP). The investigators expect to find a difference in SNP's frequency between women who had Obstetric anal sphincter injuries (OASIS) and in the healthy population. The fact that pelvic organ prolapse (POP) and OASIS occurs in the same anatomic region and the well-known association between few SNP's and the risk for POP, suggests for a common pathophysiology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2019
CompletedFirst Posted
Study publicly available on registry
August 6, 2019
CompletedStudy Start
First participant enrolled
September 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2023
CompletedMarch 26, 2025
March 1, 2025
3.1 years
August 2, 2019
March 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
difference in the frequency of of Single-nucleotide polymorphisms
difference in the relative frequency of Single-nucleotide polymorphisms between women with external anal sphincter injury that occurs during vaginal delivery and those without it.
through study completion, an average of 2 years
Secondary Outcomes (1)
genetic mutation
through study completion, an average of 2 years
Study Arms (2)
women with external anal sphincter injury
EXPERIMENTALThe study cohort will be composed of women undergoing vaginal delivery and diagnosed with external anal sphincter injury after a vaginal delivery.
women without external anal sphincter injury
EXPERIMENTALThe control group will be women who had a vaginal delivery without any clinically apparent perineal laceration
Interventions
samples from both arms will be tested for a set of single nucleotide polymorphism
samples from arm #1 (women with external anal sphincter) will be tested for identifying specific genetic mutation
Eligibility Criteria
You may qualify if:
- Women with severe external anal sphincter injury during first vaginal delivery
- Healthy women undergoing vaginal delivery without any clinically apparent perineal laceration
You may not qualify if:
- Women with known metabolic or connective-tissue disorder (e.g., Ehlers-Danlos syndrome).
- Women with known neurologic disorder
- Women undergoing episiotomy cut or assisted delivery (e.g., vacuum or forceps delivery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haemek Medical Center
Afula, Israel, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hedi Raischer, MD
haemek medical center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 2, 2019
First Posted
August 6, 2019
Study Start
September 4, 2020
Primary Completion
October 5, 2023
Study Completion
October 5, 2023
Last Updated
March 26, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share